2002
DOI: 10.1176/appi.ajp.159.2.238
|View full text |Cite
|
Sign up to set email alerts
|

Minor Physical Anomalies and Schizophrenia Spectrum Disorders: A Prospective Investigation

Abstract: Minor physical anomalies may provide important clues to understanding schizophrenia spectrum disorders from a neurodevelopmental perspective. Minor physical anomalies appear to signal stressors relevant to schizophrenia spectrum development, especially in those at genetic risk for schizophrenia.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
38
0

Year Published

2003
2003
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 71 publications
(40 citation statements)
references
References 17 publications
2
38
0
Order By: Relevance
“…There is evidence to suggest that minor physical anomalies can, in fact, discriminate between at-risk individuals and help predict outcome. In a prospective study of 81 children between the ages of 11 and 13 who had a parent diagnosed with schizophrenia, 31% of those with 3 or more minor physical anomalies subsequently developed a schizophrenia spectrum disorder, compared to only 12% of those with 0-2 physical anomalies (Schiffman et al, 2002). This is equivalent to a test sensitivity of 71% and specificity of 58%.…”
Section: Discussionmentioning
confidence: 99%
“…There is evidence to suggest that minor physical anomalies can, in fact, discriminate between at-risk individuals and help predict outcome. In a prospective study of 81 children between the ages of 11 and 13 who had a parent diagnosed with schizophrenia, 31% of those with 3 or more minor physical anomalies subsequently developed a schizophrenia spectrum disorder, compared to only 12% of those with 0-2 physical anomalies (Schiffman et al, 2002). This is equivalent to a test sensitivity of 71% and specificity of 58%.…”
Section: Discussionmentioning
confidence: 99%
“…Noncompliance as a clinical problem is multidetermined including psychopathology, medication-related factors, available social support, substance abuse comorbidity, and the quality of the therapeutic alliance [59]. Noncompliance is also caused by the fact that schizophrenic patients are a heterogeneous group with different longterm courses [68][69][70][71][72][73]. Another important reason is that on the one hand, the effects of neuroleptic treatment often improve illness symptoms, but on the other hand, the side effects of neuroleptics, especially the EPS, often simultaneously decrease the quality of patients' lives [11,36].…”
Section: Discussionmentioning
confidence: 99%
“…Patients with preexistent cerebral damage (e.g. brain damage, comorbid alcoholism and patients pretreated with high neuroleptic doses over a longer period of time) are more likely to develop EPS and dyskinesia [73,76,77]. This is why we consider that these patients have a greater benefit from risperidone or other atypical neuroleptics.…”
Section: Discussionmentioning
confidence: 99%
“…We have described the design of the study, the subject characteristics, and the premorbid and follow-up diagnoses in greater detail elsewhere (14).…”
Section: Methodsmentioning
confidence: 99%